Abstracts - faqs.org

Abstracts

Business

Search abstracts:
Abstracts » Business

Wells Fargo & Co

Article Abstract:

Warren Buffett invested another $37 million on Wells Fargo and Co, thus, increasing his stakes from 10.8 to 11.8%. The stock purchase, however, failed to foster optimism about the firm. Earnings for the Sep 1992 quarter stood at a minimal 21 cents per share while non-performing loans rose to $2.4 billion. There is pessimism whether the company can preserve its quarterly dividends after it sustained a 24-cent operating loss for the Sep 1992 quarter. Some analysts are not even encouraged by positive developments on net interest margins and capital ratios.

Publisher: Thomson Financial Inc.
Publication Name: The Insiders' Chronicle
Subject: Business
ISSN: 0162-5152
Year: 1992
State commercial banks, Wells Fargo & Co.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Sovereign Bancorp Inc

Article Abstract:

Sovereign Bancorp Chmn Frederick Jaindl is very bullish about the firm considering a Sep 1992 quarter gain and a nine-month profit of 86% and 93%, respectively. The figures prompted Jaindl to buy another 200,000 shares, thus, increasing his stakes to 15.88%. Four other Sovereign officials, purchased 36,000 shares at 10 1/2 to 10 5/8. The firm has also disclosed a six-for-five stock split and a quarterly dividend raise to reflect the projected 3rd qtr 1992 growth and the acquisition of Jersey Shore Savings and Loan.

Publisher: Thomson Financial Inc.
Publication Name: The Insiders' Chronicle
Subject: Business
ISSN: 0162-5152
Year: 1992
Savings institutions, except federal, Sovereign Bancorp Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: Securities, Bank holding companies
Similar abstracts:
  • Abstracts: Monsanto Co. Circuit City Stores Inc. Matrix Pharmaceutical Inc
  • Abstracts: Alltel Corp. ALC Communications Corp. C-Tec Corp
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.